Delivery Order SPE2DR25D2104-SPE2DR26F3SZB
- Not listed
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $10,196.54 by the Defense Logistics Agency on January 6, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order on November 4, 2025, by the Defense Logistics Agency for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a competitively awarded, firm fixed-price delivery order with a ceiling value of $15,222.77 and an ultimate completion date of November 5, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $36,311.17 for Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on November 12, 2025, with an ultimate completion date of November 13, 2025. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply relationship with...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,340.28 by the Defense Logistics Agency on August 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by August 5, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a $7,085.19 delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $37,890.91 firm fixed price delivery order from the Defense Logistics Agency (DLA) on December 18, 2025, with an ultimate completion date of December 19, 2025. The delivery order, designated as contract number 4570325745, is for Repatha 140 mg/ml SureClick auto-injectors and was awarded without a set-aside designation through competitive procurement. This award falls under...
- The Defense Logistics Agency awarded a $38,297.64 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 19, 2025, with performance taking place at the vendor's Conshohocken, Pennsylvania headquarters. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,880.79 by the Defense Logistics Agency on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract, issued under a firm fixed price arrangement, covers the supply of Repatha 140 mg/ml SureClick auto-injectors. This delivery order was competitively awarded with no set-aside designation and represents a child award...
- The Defense Logistics Agency awarded a $15,827.33 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion deadline of December 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The place of performance...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,026.16 by the Defense Logistics Agency on December 5, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by December 8, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3SZBDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order valued at $3,433.78 from the Defense Logistics Agency (DLA) on January 6, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be completed at the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply agreement running through December 2026 that serves as the primary vehicle for delivering medications and medical supplies to military healthcare systems worldwide. The Repatha product supplied under this delivery order is a monoclonal antibody used for cholesterol management and cardiovascular disease prevention, reflecting the types of specialty pharmaceuticals that DLA procures to support military treatment facilities and other federal healthcare systems. Amerisourcebergen's extensive federal contract portfolio with DLA demonstrates the company's established capability to fulfill government medical supply requirements through open competition across diverse therapeutic domains including cardiology, diabetes, oncology, and pain management. The rapid completion timeline reflects the time-sensitive nature of pharmaceutical procurement within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 1/5/26 |